{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T14:30:17Z","timestamp":1790605817059,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010258","name":"The Marfan Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010258","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PTJ159627"],"award-info":[{"award-number":["PTJ159627"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004411","name":"Heart and Stroke Foundation of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004489","name":"Mitacs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004489","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012453","name":"Providence Health Care","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012453","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.ejphar.2024.176663","type":"journal-article","created":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T18:24:46Z","timestamp":1716920686000},"page":"176663","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Losartan and metabolite EXP3179 activate endothelial function without lowering blood pressure in AT2 receptor KO mice"],"prefix":"10.1016","volume":"977","author":[{"given":"Elodie","family":"Sauge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farah","family":"Lizotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9749-4593","authenticated-orcid":false,"given":"Christopher","family":"Yuen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N D Prasad","family":"Atmuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco A.","family":"Ciufolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2613-6710","authenticated-orcid":false,"given":"Pedro","family":"Geraldes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3198-1548","authenticated-orcid":false,"given":"Pascal","family":"Bernatchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2024.176663_bib1","doi-asserted-by":"crossref","unstructured":"Ancion, A., Tridetti, Julien, Nguyen Trung, Mai-Linh, Oury, C\u00e9cile, Lancellotti, Patrizio, n.d. A Review of the Role of Bradykinin and Nitric Oxide in the Cardioprotective Action of Angiotensin-Converting Enzyme Inhibitors: Focus on Perindopril. Cardiology and Therapy 8. Available at: https:\/\/doi.org\/10.6084\/m9.figshare.9896510.","DOI":"10.1007\/s40119-019-00150-w"},{"issue":"2","key":"10.1016\/j.ejphar.2024.176663_bib2","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1161\/01.ATV.0000051384.43104.FC","article-title":"Endothelial dysfunction: a marker of atherosclerotic risk","volume":"23","author":"Bonetti","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"12","key":"10.1016\/j.ejphar.2024.176663_bib3","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy","volume":"345","author":"Brenner","year":"2001","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.ejphar.2024.176663_bib4","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1046\/j.1365-201x.2000.00660.x","article-title":"Nitric oxide: a physiological mediator of the type 2 (AT2) angiotensin receptor","volume":"168","author":"Carey","year":"2000","journal-title":"Acta Physiol. Scand."},{"issue":"4","key":"10.1016\/j.ejphar.2024.176663_bib5","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1524-6175.2005.05264.x","article-title":"The pleiotropic effects of angiotensin receptor blockers | enhanced reader","volume":"8","author":"Chrysant","year":"2006","journal-title":"J. Clin. Hypertens."},{"issue":"4","key":"10.1016\/j.ejphar.2024.176663_bib6","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.amjhyper.2004.11.007","article-title":"Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonists","volume":"18","author":"Cosentino","year":"2005","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.ejphar.2024.176663_bib7","series-title":"\u2018Does Blockade of Angiotensin II Receptors Offer Clinical Benefits over Inhibition of Angiotensin-Converting Enzyme?\u2019, Pharmacology and Toxicology","first-page":"257","author":"De Gasparo","year":"1998"},{"issue":"8","key":"10.1016\/j.ejphar.2024.176663_bib8","doi-asserted-by":"crossref","first-page":"797","DOI":"10.2165\/00003088-200544080-00003","article-title":"Clinical pharmacokinetics of losartan","volume":"44","author":"Domenic","year":"2005","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejphar.2024.176663_bib9","article-title":"Physiology, renin angiotensin system","author":"Fountain","year":"2021","journal-title":"StatPearls"},{"issue":"Suppl. 1","key":"10.1016\/j.ejphar.2024.176663_bib10","article-title":"Reduction of proteinuria with angiotensin receptor blockers","volume":"5","author":"Galle","year":"2008","journal-title":"Nat. Clin. Pract. Cardiovasc. Med."},{"issue":"9","key":"10.1016\/j.ejphar.2024.176663_bib11","doi-asserted-by":"crossref","first-page":"812","DOI":"10.2174\/138955712800959134","article-title":"Biased agonism of the angiotensin II type 1 receptor","volume":"12","author":"Godin","year":"2012","journal-title":"Mini-Rev. Med. Chem."},{"key":"10.1016\/j.ejphar.2024.176663_bib12","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.neuroscience.2012.11.048","article-title":"Angiotensin (5-8) modulates nociception at the rat periaqueductal gray via the NO-sGC pathway and an endogenous opioid","volume":"231","author":"Guethe","year":"2013","journal-title":"Neuroscience"},{"issue":"5770","key":"10.1016\/j.ejphar.2024.176663_bib13","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1126\/science.1124287","article-title":"Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome.[see comment]","volume":"312","author":"Habashi","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2024.176663_bib14","author":"Hollenberg"},{"issue":"3","key":"10.1016\/j.ejphar.2024.176663_bib15","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.pharmthera.2008.08.009","article-title":"AT2 receptors: functional relevance in cardiovascular disease","volume":"120","author":"Jones","year":"2008","journal-title":"Pharmacology and Therapeutics"},{"key":"10.1016\/j.ejphar.2024.176663_bib16","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.phrs.2017.07.008","article-title":"AT2 receptors in cardiovascular and renal diseases","volume":"125","author":"Kaschina","year":"2017","journal-title":"Pharmacol. Res."},{"issue":"3","key":"10.1016\/j.ejphar.2024.176663_bib17","doi-asserted-by":"crossref","first-page":"3868","DOI":"10.3390\/molecules20033868","article-title":"Rational drug design and synthesis of molecules targeting the angiotensin II type 1 and type 2 receptors","volume":"20","author":"Kellici","year":"2015","journal-title":"Molecules"},{"issue":"11","key":"10.1016\/j.ejphar.2024.176663_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0164778","article-title":"Aortic and cardiac structure and function using high-resolution echocardiography and optical coherence tomography in a mouse model of marfan syndrome","volume":"11","author":"Lee","year":"2016","journal-title":"PLoS One"},{"issue":"6 Suppl. l","key":"10.1016\/j.ejphar.2024.176663_bib19","first-page":"III12","article-title":"Intact and altered endothelium in regulation of vasomotion","volume":"86","author":"Lerman","year":"1992","journal-title":"Circulation"},{"issue":"21","key":"10.1016\/j.ejphar.2024.176663_bib20","doi-asserted-by":"crossref","first-page":"11483","DOI":"10.1073\/pnas.1922608117","article-title":"\u03b2-Arrestin2 is a critical component of the GPCR-eNOS signalosome","volume":"117","author":"Liu","year":"2020","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"16","key":"10.1016\/j.ejphar.2024.176663_bib21","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/j.jacc.2011.11.082","article-title":"Endothelial dysfunction, arterial stiffness, and heart failure","volume":"60","author":"Marti","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2024.176663_bib22","article-title":"The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: gain-of-function study using gene transfer","author":"Nakajima","year":"1995","journal-title":"Physiology"},{"key":"10.1016\/j.ejphar.2024.176663_bib23","author":"Nelson"},{"issue":"1","key":"10.1016\/j.ejphar.2024.176663_bib24","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1172\/JCI117675","article-title":"Regulation of gene transcription of angiotensin II receptor subtypes in myocardial infarction","volume":"95","author":"Nio","year":"1995","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.ejphar.2024.176663_bib25","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0022-3565(25)10800-8","article-title":"The antihypertensive effect of the angiotensin II receptor antagonist DuP 753 may not be due solely to angiotensin II receptor antagonism","volume":"262","author":"Ohlstein","year":"1992","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"1","key":"10.1016\/j.ejphar.2024.176663_bib26","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s12020-012-9659-2","article-title":"The effects of angiotensin peptides and angiotensin receptor antagonists on the cell growth and angiogenic activity of GH3 lactosomatotroph cells in vitro","volume":"42","author":"Ptasinska-Wnuk","year":"2012","journal-title":"Endocrine"},{"issue":"6","key":"10.1016\/j.ejphar.2024.176663_bib27","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1124\/molpharm.121.000236","article-title":"Update on angiotensin II subtype 2 receptor: focus on peptide and nonpeptide agonists","volume":"99","author":"Ranjit","year":"2021","journal-title":"Mol. Pharmacol."},{"issue":"4","key":"10.1016\/j.ejphar.2024.176663_bib28","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1161\/HYPERTENSIONAHA.109.138883","article-title":"Losartan metabolite EXP3179: an AT1-receptor-independent treatment strategy for patients with the metabolic syndrome?","volume":"54","author":"Rossi","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2024.176663_bib29","author":"Sales"},{"key":"10.1016\/j.ejphar.2024.176663_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.vph.2022.107112","article-title":"Losartan metabolite EXP3179 is a unique blood pressure-lowering AT1R antagonist with direct, rapid endothelium-dependent vasoactive properties","volume":"147","author":"Sauge","year":"2022","journal-title":"Vasc. Pharmacol."},{"issue":"5","key":"10.1016\/j.ejphar.2024.176663_bib32","doi-asserted-by":"crossref","DOI":"10.1097\/01.hjh.0000166845.49850.39","article-title":"Negative regulation of RhoA\/Rho kinase by angiotensin II type 2 receptor in vascular smooth muscle cells: role in angiotensin II-induced vasodilation in stroke-prone spontaneously hypertensive rats","volume":"23","author":"Savoia","year":"2005","journal-title":"J. Hypertens."},{"issue":"3","key":"10.1016\/j.ejphar.2024.176663_bib33","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.ajpath.2017.11.006","article-title":"Inhibition of marfan syndrome aortic root dilation by losartan: role of angiotensin II receptor type 1\u2013independent activation of endothelial function","volume":"188","author":"Sellers","year":"2018","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ejphar.2024.176663_bib34","author":"Siragy"},{"issue":"5","key":"10.1016\/j.ejphar.2024.176663_bib36","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1161\/01.HYP.35.5.1074","article-title":"Angiotensin type 2 receptor mediates valsartan-induced hypotension in conscious rats","volume":"35","author":"Siragy","year":"2000","journal-title":"Hypertension (Dallas, Tex. : 1979)"},{"issue":"10","key":"10.1016\/j.ejphar.2024.176663_bib38","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.14877","article-title":"Blood pressure-independent inhibition of Marfan aortic root widening by the angiotensin II receptor blocker valsartan","volume":"9","author":"Tehrani","year":"2021","journal-title":"Physiological reports"},{"issue":"1","key":"10.1016\/j.ejphar.2024.176663_bib39","doi-asserted-by":"crossref","first-page":"9771","DOI":"10.1038\/s41598-022-13772-3","article-title":"Pleiotropic activation of endothelial function by angiotensin II receptor blockers is crucial to their protective anti-vascular remodeling effects","volume":"12","author":"Tehrani","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2024.176663_bib40","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.niox.2022.12.002","article-title":"Heterogenous improvements in endothelial function by sub-blood pressure lowering doses of ARBs result in major anti-aortic root remodeling effects","volume":"131","author":"Tehrani","year":"2023","journal-title":"Nitric Oxide"},{"issue":"3","key":"10.1016\/j.ejphar.2024.176663_bib41","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0033-0620(96)80003-X","article-title":"Vascular endothelium: vasoactive mediators","volume":"39","author":"Vanhoutte","year":"1996","journal-title":"Prog. Cardiovasc. Dis."},{"issue":"1","key":"10.1016\/j.ejphar.2024.176663_bib42","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/apha.12646","article-title":"Endothelial dysfunction and vascular disease \u2013 a 30th anniversary update","volume":"219","author":"Vanhoutte","year":"2017","journal-title":"Acta Physiol."},{"issue":"8","key":"10.1016\/j.ejphar.2024.176663_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0220903","article-title":"Angiotensin II receptor blocker losartan exacerbates muscle damage and exhibits weak blood pressure-lowering activity in a dysferlin-null model of Limb-Girdle muscular dystrophy type 2B","volume":"14","author":"White","year":"2019","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.ejphar.2024.176663_bib44","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/j.ajpath.2019.05.003","article-title":"Sildenafil prevents marfan-associated emphysema and early pulmonary artery dilation in mice","volume":"189","author":"White","year":"2019","journal-title":"Am. J. Pathol."},{"issue":"4","key":"10.1016\/j.ejphar.2024.176663_bib45","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1161\/01.HYP.0000033224.99806.8A","article-title":"AT2 receptor-mediated relaxation is preserved after long-term AT1 receptor blockade","volume":"40","author":"Widdop","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2024.176663_bib46","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1253\/circj.CJ-14-0470","article-title":"Insights into the activation and inhibition of angiotensin II type 1 receptor in the mechanically loaded heart","author":"Wu","year":"2014","journal-title":"Circulation Journal. Japanese Circulation Society"},{"issue":"49","key":"10.1016\/j.ejphar.2024.176663_bib47","doi-asserted-by":"crossref","first-page":"29127","DOI":"10.1074\/jbc.M115.689000","article-title":"Structural basis for ligand recognition and functional selectivity at angiotensin receptor","volume":"290","author":"Zhang","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2024.176663_bib48","series-title":"Journal of the Renin-Angiotensin-Aldosterone System Effects of Losartan on Haemodynamic Parameters and Angiotensin Receptor mRNA Levels in Rat Heart after Myocardial Infarction","author":"Zhu","year":"2000"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299924003510?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299924003510?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T05:01:28Z","timestamp":1778648488000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299924003510"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":45,"alternative-id":["S0014299924003510"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2024.176663","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Losartan and metabolite EXP3179 activate endothelial function without lowering blood pressure in AT2 receptor KO mice","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2024.176663","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"176663"}}